Directori de persones
Sonia Gatius Caldero

Sonia Gatius Caldero

Grau: Doctor/a

973 705312
sgatius.lleida.ics(ELIMINAR)@gencat.cat

Grups

Publicacions

  • Jove, M; Gatius, S; Yeramian, A; Portero-Otin, M; Eritja, N; Santacana, M; Colas, E; Ruiz, M; Pamplona, R; Matias-Guiu, X

    Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget 7 52364-52374. .

    [doi:10.18632/oncotarget.10564]

  • Hellner, K; Miranda, F; Fotso Chedom D; Herrero-Gonzalez, S; Hayden, DM; Tearle, R; Artibani, M; KaramiNejadRanjbar, M; Williams R; Gaitskell, K; Elorbany, S; Xu, RY; Laios, A; Buiga, P; Ahmed, K; Dhar, S; Zhang, RY; Campo, L; Myers, KA; Lozano, M; Ruiz-Miro, M; Gatius, S; Mota, A; Moreno-Bueno, G; Matias-Guiu, X; Benitez, J; Witty, L; McVean, G; Leedham, S; Tomlinson, I; Drmanac, R; Cazier, JB; Klein, R; Dunne, K; Bast, RC; Kennedy, SH; Hassan, B; Lise, S; Garcia, MJ; Peters, BA; Yau, C; Sauka-Spengler, T; Ahmed, AA

    Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies

    EBioMedicine 10 137-149. .

    [doi:10.1016/j.ebiom.2016.06.048]

  • Mirantes, C; Dosil, MA; Eritja, N; Felip, I; Gatius, S; Santacana, M; Matias-Guiu, X; Dolcet, X

    Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasias

    EUROPEAN JOURNAL OF CANCER 63 74-87. .

    [doi:10.1016/j.ejca.2016.04.019]

  • Schultheis, AM; Ng, CKY; De Filippo, MR; Piscuoglio, S; Macedo, GS; Gatius, S; Perez Mies B; Soslow, RA; Lim, RS; Viale, A; Huberman, KH; Palacios, JC; Reis-Filho, JS; Matias-Guiu, X; Weigelt, B

    Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas

    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 108 -. .

    [doi:10.1093/jnci/djv427]

  • Fuste, NP; Castelblanco, E; Felip, I; Santacana, M; Fernandez-Hernandez, R; Gatius, S; Pedraza, N; Pallares, J; Cemeli, T; Valls, J; Tarres, M; Ferrezuelo, F; Dolcet, X; Matias-Guiu, X; Gari, E

    Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer

    Oncotarget 7 26979-26991. .

    [doi:10.18632/oncotarget.8876]

  • Mirantes, C; Dosil, MA; Hills, D; Yang, J; Eritja, N; Santacana, M; Gatius, S; Vilardell, F; Medvinsky, A; Matias-Guiu, X; Dolcet, X

    Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies

    Blood 127 1907-1911. .

    [doi:10.1182/blood-2015-09-669036]

  • Eritja, N; Arjo, G; Santacana, M; Gatius, S; Ramirez-Nunez, O; Arcal, L; Serrano, JCE; Pamplona, R; Dolcet, X; Pinol, C; Christou, P; Matias-Guiu, X; Portero-Otin, M

    Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1862 526-535. .

    [doi:10.1016/j.bbadis.2016.01.018]

  • Del Carmen S; Gatius S; Franch-Arcas G; Baena JA; Gonzalez O; Zafon C; Cuevas D; Valls J; Pérez A; Martinez M; Ros S; Macías CG; Iglesias C; Matías-Guiu X; de Álava E

    Concordance study between one-step nucleic acid amplification and morphologic techniques to detect lymph node metastasis in papillary carcinoma of the thyroid

    HUMAN PATHOLOGY 48 132-141. .

    [doi:10.1016/j.humpath.2015.09.020]

  • Gatius, S; Matias-Guiu, X

    Practical issues in the diagnosis of serous carcinoma of the endometrium

    Modern Pathology 29 45-58. .

    [doi:10.1038/modpathol.2015.141]

  • Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A

    TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions

    RESPIROLOGY 20 831-833. .

    [doi:10.1111/resp.12543]

  • Coenegrachts L; Garcia-Dios DA; Depreeuw J; Santacana M; Gatius S; Zikan M; Moerman P; Verbist L; Lambrechts D; Matias-Guiu X; Amant F

    Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas

    VIRCHOWS ARCHIV 466 415-422. .

    [doi:10.1007/s00428-015-1728-5]

  • Santacana M; Maiques O; Valls J; Gatius S; Abó AI; López-García MÁ; Mota A; Reventós J; Moreno-Bueno G; Palacios J; Bartosch C; Dolcet X; Matias-Guiu X

    A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    HUMAN PATHOLOGY 45 2394-2403. .

    [doi:10.1016/j.humpath.2014.06.031]

Projectes

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • Clinical and functional identification of metastatic colonization biomarkers.
  • Papel de ARID1A en la carcinogénesis endometrial dependiente de contexto. Análisis de los mecanismos moleculares y posibles implicaciones terapéuticas
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares